 |
27 Diseases |  |
7 Trials |
|
7 Trials |  |
733 News |  |
| «123456789 |
- ||||||| Lantus (insulin glargine) / Sanofi, Lyxumia (lixisenatide) / Zealand Pharma, Sanofi
Trial completion: GetGoal Duo1: 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine (clinicaltrials.gov) - Aug 7, 2011
P3, N=446, Completed, Sponsor: Sanofi
Active, not recruiting --> Completed